Shyam K Daya

Novel Brentuximab Vedotin Combination Therapies Show Promising Activity in Highly Refractory CD30+ Non-Hodgkin Lymphoma: A Case Series and Review of the Literature

R. Setlik, A. Hassantoufighi, D. Selby, 2016, Case reports in oncological medicine.